Your browser doesn't support javascript.
loading
The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy.
Chiang, Cho-Han; Chang, Yu-Cheng; Wang, Shih-Syuan; Chen, Yuan-Jen; See, Xin Ya; Peng, Chun-Yu; Hsia, Yuan Ping; Chiang, Cho-Hsien; Chiang, Cho-Hung; Peng, Cheng-Ming.
Affiliation
  • Chiang CH; Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Chang YC; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Wang SS; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Chen YJ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • See XY; Department of Medicine, Unity Hospital, Rochester Regional Health, Rochester, New York, USA.
  • Peng CY; Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA.
  • Hsia YP; Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
  • Chiang CH; Department of Medical Education, Kuang Tien General Hospital, Taichung, Taiwan.
  • Chiang CH; London School of Hygiene & Tropical Medicine, London, UK.
  • Peng CM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Cancer Med ; 12(8): 9583-9588, 2023 04.
Article in En | MEDLINE | ID: mdl-36825549
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin II Type 1 Receptor Blockers / Angiotensin Receptor Antagonists Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin II Type 1 Receptor Blockers / Angiotensin Receptor Antagonists Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication: